Clindamycin in pharma franchise in Gujarat

Clindamycin in PCD pharma franchise in Kohima

Clindamycin in top pharma company in Raipur

Clindamycin in pcd pharma supplier in Chandigarh

Clindamycin in phama franchise company in India
Clindamycin in phama distributor in Agartala

Home/Products /clindamycin-i-point-p-point-100mg-clotrimazole-capsules-softgel

Clinzadin Forte Softgel

Composition : Clindamycin I.P. 100mg + Clotrimazole I.P. 100mg + Tinidazole I.P. 100mg Softgel Capsules

Dosage Form : Softgel

Packaging Type : Blister

Packaging : 10x1x7

Price : ₹251/-

Clinzadin Forte Softgel is a comprehensive combination medication containing Clindamycin I.P. 100mg, Clotrimazole I.P. 100mg, and Tinidazole I.P. 100mg. It is specially formulated to address mixed vaginal infections, providing a broad spectrum of action against bacterial, fungal, and protozoal pathogens.

  • Clindamycin, a lincosamide antibiotic, inhibits bacterial protein synthesis, effectively targeting anaerobic bacteria responsible for bacterial vaginosis.
  • Clotrimazole, an antifungal agent, disrupts fungal cell membranes by inhibiting ergosterol synthesis, treating and preventing fungal infections such as vaginal candidiasis.
  • Tinidazole, an antiprotozoal and antibacterial agent, eliminates protozoa and anaerobic bacteria by damaging their DNA, making it effective against infections like trichomoniasis.

This unique combination ensures targeted action against multiple pathogens, offering relief from symptoms such as abnormal vaginal discharge, itching, burning, and odor. Clinzadin Forte Softgel provides a convenient and effective solution for managing complex vaginal infections, ensuring high compliance and rapid recovery.

Read More

About the Product

Clinzadin Forte Softgel is a comprehensive combination medication containing Clindamycin I.P. 100mg, Clotrimazole I.P. 100mg, and Tinidazole I.P. 100mg. It is specially formulated to address mixed vaginal infections, providing a broad spectrum of action against bacterial, fungal, and protozoal pathogens.

  • Clindamycin, a lincosamide antibiotic, inhibits bacterial protein synthesis, effectively targeting anaerobic bacteria responsible for bacterial vaginosis.
  • Clotrimazole, an antifungal agent, disrupts fungal cell membranes by inhibiting ergosterol synthesis, treating and preventing fungal infections such as vaginal candidiasis.
  • Tinidazole, an antiprotozoal and antibacterial agent, eliminates protozoa and anaerobic bacteria by damaging their DNA, making it effective against infections like trichomoniasis.

This unique combination ensures targeted action against multiple pathogens, offering relief from symptoms such as abnormal vaginal discharge, itching, burning, and odor. Clinzadin Forte Softgel provides a convenient and effective solution for managing complex vaginal infections, ensuring high compliance and rapid recovery.

Possible side effects include mild vaginal irritation, burning sensation, nausea, or abdominal discomfort. These are generally transient and resolve without intervention.

Clinzadin Forte Softgel is indicated for the treatment of mixed vaginal infections, including bacterial vaginosis, vaginal candidiasis, and trichomoniasis.

For intravaginal use only. Avoid use during menstruation. Consult a healthcare provider if symptoms persist or worsen after use.

Store in a cool, dry place below 30°C. Keep the medication away from direct sunlight and moisture. Ensure it is stored out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation